Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 319

1.

Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.

Pesta M, Fichtl J, Kulda V, Topolcan O, Treska V.

Anticancer Res. 2013 May;33(5):2239-43.

PMID:
23645782
2.

Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.

Mikulová V, Cabiňaková M, Janatková I, Mestek O, Zima T, Tesařová P.

Scand J Clin Lab Invest. 2014 Mar;74(2):132-42. doi: 10.3109/00365513.2013.864784. Epub 2013 Dec 19.

PMID:
24350991
3.

Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer.

Zieglschmid V, Hollmann C, Mannel J, Albert W, Jaeschke-Melli S, Eckstein B, Hillemann T, Greten TF, Gross E, Böcher O.

Anticancer Res. 2007 Jul-Aug;27(4A):1823-32.

4.

Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells.

Lankiewicz S, Rother E, Zimmermann S, Hollmann C, Korangy F, Greten TF.

Cell Oncol. 2008;30(6):463-71.

5.

Clinico-pathological correlation of serial measurement of circulating tumor cells in 24 metastatic colorectal cancer patients receiving chemotherapy reveals interpatient heterogeneity correlated with CEA levels but independent of KRAS and BRAF mutation.

Das A, Kunkel M, Joudeh J, Dicker DT, Scicchitano A, Allen JE, Sarwani N, Yang Z, Kaifi J, Zhu J, Liao J, El-Deiry WS.

Cancer Biol Ther. 2015;16(5):709-13. doi: 10.1080/15384047.2015.1030555.

6.

Unique localization of circulating tumor cells in patients with hepatic metastases.

Jiao LR, Apostolopoulos C, Jacob J, Szydlo R, Johnson N, Tsim N, Habib NA, Coombes RC, Stebbing J.

J Clin Oncol. 2009 Dec 20;27(36):6160-5. doi: 10.1200/JCO.2009.24.5837. Epub 2009 Nov 2.

PMID:
19884529
7.

Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.

Zhao S, Yang H, Zhang M, Zhang D, Liu Y, Liu Y, Song Y, Zhang X, Li H, Ma W, Zhang Q.

Cell Biochem Biophys. 2013 Mar;65(2):263-73. doi: 10.1007/s12013-012-9426-2.

PMID:
22990361
8.

Clinical impact of carcinoembryonic antigen messenger ribonucleic acid expression in tumor-draining vein blood on postoperative liver metastasis in patients with colorectal carcinoma: a prospective, cohort study.

Sunouchi K, Machinami R, Mori M, Namiki K, Hattori S, Murata Y, Tsuchiya T, Mizuno H, Tadokoro M.

Dis Colon Rectum. 2003 Apr;46(4):467-73.

PMID:
12682539
9.

Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.

Shimada R, Iinuma H, Akahane T, Horiuchi A, Watanabe T.

Oncol Rep. 2012 Apr;27(4):947-53. doi: 10.3892/or.2012.1649. Epub 2012 Jan 19.

10.

Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.

Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J.

Cancer Res. 2001 Mar 15;61(6):2523-32.

11.

Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases.

Brudvik KW, Seeberg LT, Hugenschmidt H, Renolen A, Schirmer CB, Brunborg C, Bjørnbeth BA, Borgen E, Naume B, Waage A, Wiedswang G.

Ann Surg Oncol. 2015 Nov;22(12):4029-37. doi: 10.1245/s10434-015-4482-7. Epub 2015 Mar 24.

PMID:
25801354
12.

Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.

Obermayr E, Sanchez-Cabo F, Tea MK, Singer CF, Krainer M, Fischer MB, Sehouli J, Reinthaller A, Horvat R, Heinze G, Tong D, Zeillinger R.

BMC Cancer. 2010 Dec 3;10:666. doi: 10.1186/1471-2407-10-666.

13.

Detection of circulating tumor cells in peripheral blood of colorectal cancer patients without distant organ metastases.

Liu Y, Qian J, Feng JG, Ju HX, Zhu YP, Feng HY, Li DC.

Cell Oncol (Dordr). 2013 Feb;36(1):43-53. doi: 10.1007/s13402-012-0112-6. Epub 2012 Nov 14.

PMID:
23150200
14.

Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.

Hinz S, Bockhorst J, Röder C, Egberts JH, Schafmayer C, Küchler T, Becker T, Kalthoff H.

Ann Surg Oncol. 2012 Aug;19(8):2539-46. doi: 10.1245/s10434-012-2291-9. Epub 2012 Mar 7.

PMID:
22395998
15.

Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.

Uen YH, Lin SR, Wu DC, Su YC, Wu JY, Cheng TL, Chi CW, Wang JY.

Ann Surg. 2007 Dec;246(6):1040-6.

PMID:
18043108
16.

Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.

Sun YF, Xu Y, Yang XR, Guo W, Zhang X, Qiu SJ, Shi RY, Hu B, Zhou J, Fan J.

Hepatology. 2013 Apr;57(4):1458-68. doi: 10.1002/hep.26151. Epub 2013 Mar 4.

PMID:
23175471
18.

Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.

Iinuma H, Watanabe T, Mimori K, Adachi M, Hayashi N, Tamura J, Matsuda K, Fukushima R, Okinaga K, Sasako M, Mori M.

J Clin Oncol. 2011 Apr 20;29(12):1547-55. doi: 10.1200/JCO.2010.30.5151. Epub 2011 Mar 21.

PMID:
21422427
19.

Early Assessment of Colorectal Cancer by Quantifying Circulating Tumor Cells in Peripheral Blood: ECT2 in Diagnosis of Colorectal Cancer.

Chen CJ, Sung WW, Chen HC, Chern YJ, Hsu HT, Lin YM, Lin SH, Peck K, Yeh KT.

Int J Mol Sci. 2017 Mar 31;18(4). pii: E743. doi: 10.3390/ijms18040743.

20.

Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.

Schulze K, Gasch C, Staufer K, Nashan B, Lohse AW, Pantel K, Riethdorf S, Wege H.

Int J Cancer. 2013 Nov;133(9):2165-71. doi: 10.1002/ijc.28230. Epub 2013 Jun 11.

Supplemental Content

Support Center